Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
10,710 total articles
Keinan Tal, the Chief Executive Officer of Sky Harbour Group Corp., purchased additional shares on May 18, 2026. This buying activity occurred while the stock was trading significantly lower over recent weeks and months. Separately, the company reported first-quarter 2026 financial results that missed analyst expectations for both earnings per shar…
Director Chris Hadfield recently acquired a block of Momentus Inc. Class A Common Stock, an insider transaction that occurs as the stock trades at $6.13, following significant decline over the past year. The news comes amidst several corporate announcements detailing major contract awards from government entities like NASA and the U.S. Department o…
Williams-Sonoma Inc. (WSM) President and CEO Laura Alber completed a stock sale totaling $3.45 million on May 14, 2026. This transaction involved the divestment of 20,000 shares through a prearranged trading plan. Despite the executive selling activity, recent analyst coverage highlights both financial concerns, such as margin pressures, and positi…
Gitlab director Sytse Sijbrandij sold shares of the company's Class A common stock totaling $2.89 million in transactions conducted through his trust. This insider selling occurred as the stock has declined significantly over the past year, while the company simultaneously navigates a restructuring initiative and faces multiple analyst downgrades c…
Johanna Mercier, Gilead Sciences' Chief Communications & Corporate Affairs Officer, executed a mixed transaction involving the sale and purchase of common stock on May 15, 2026. These actions were conducted under a pre-established Rule 10b5-1 trading plan. In parallel corporate developments, Gilead recently reported strong first-quarter earning…
Sean Chihhsiang Chen, President and Chief Operating Officer of Ambiq Micro, Inc., executed a significant sale of common stock totaling approximately $3.947 million on May 15, 2026. This transaction occurred as the company's stock trades close to its 52-week high of $73.72, following substantial gains over the past six months. The filing details mul…
Neurocrine Biosciences director, Richard F. Pops, recently executed a complex series of stock transactions involving both selling shares via a pre-arranged plan and acquiring additional common stock through option exercises. These insider movements occur against a backdrop of robust corporate performance, including beating Q1 earnings expectations …
Despite the recent sale of shares by Chief Financial Officer Andrew D. Dickinson, Gilead Sciences Inc. (NASDAQ:GILD) continues to demonstrate strong operational momentum. The company reported first-quarter 2026 earnings that surpassed market expectations, leading to updated revenue guidance and strategic financial moves.
OPAL Fuels director, Nisar Nadeem, recently acquired a total of 20,000 shares of the company's Class A common stock across two transactions in May 2026. This activity occurs while OPAL shares have experienced an 11% decline over the past week and following the release of disappointing first-quarter earnings for 2026.
Director Brian C. Healy of Mueller Water Products, Inc. (NASDAQ:MWA) recently acquired a significant block of the company’s common stock. This insider transaction occurred against a backdrop of recent positive financial disclosures for Q2 2026 and suggests internal confidence in the firm's current valuation and operational trajectory.
The Chief Executive Officer of Ambiq Micro, Inc., Esaka Fumihide, recently engaged in significant stock activity, including the sale of shares following the exercise of options. This transaction occurred against a backdrop of strong recent financial reporting from the company, where Q1 2026 earnings and revenue surpassed market expectations.
Saba Capital Management, L.P., a significant stakeholder in the BlackRock ESG Capital Allocation Term Trust (NASDAQ:ECAT), recently executed transactions involving the sale of its common stock holdings. These dispositions occurred over two days, with shares sold at various price points between $15.25 and $15.69 per share. The report details these s…
Kestra Medical Technologies CEO, Brian Daniel Webster, sold shares totaling $314,329 on May 15, 2026. These sales occurred despite a backdrop of negative stock performance over the past week and year-to-date. However, recent company news includes a significant earnings miss for Q3 2026, which was counterbalanced by strong revenue growth and positiv…
Juniper Investment Company, LLC, an affiliate, conducted significant sales of common stock in Lincoln Educational Services Corp (LINC) between May 14 and May 15, 2026. These transactions totaled $2.54 million for 49,821 shares. The sales occurred while LINC's stock price traded near its 52-week high of $53.50, following a substantial 126% gain over…
William Matthew Woodruff, a Vice President at Kirby Corp., sold shares totaling $99,916 on May 15, 2026. This transaction occurs against a backdrop of positive corporate news: the company reported Q1 2026 results that exceeded expectations and subsequently raised its full-year EPS growth guidance. Following these developments, BofA Securities incre…
HF Sinclair Corp's Executive Vice President of Operations, Valerie Pompa, sold 10,000 shares of the company's common stock on May 15, 2026. This transaction was reported to the Securities and Exchange Commission (SEC) via a Form 4 filing on May 18, 2026.The sale generated total proceeds of $690,500 for Ms. Pompa, averaging $69.05 per share across m…
Director Richard A. Damore recently sold a substantial amount of Veeco Instruments Inc. common stock in a transaction totaling over $2.65 million. This activity occurs against the backdrop of significant volatility for the company, which saw an 185% increase over the past year, coupled with mixed financial results reported for the first quarter of …
Amy D. Husted, an executive at Kirby Corp, sold a significant number of common shares in May 2026. This transaction occurred against the backdrop of strong corporate performance for Kirby Corporation, which surpassed expectations in its first quarter of 2026 and subsequently raised its growth projections for the full year.
Donald R. Chase, a director at Bluejay Diagnostics, Inc., purchased $25,000 worth of common stock on March 14, 2026. This transaction occurred as the company's stock price traded near its 52-week low. The purchase follows other corporate developments, including a recent private placement and the full exercise of prefunded warrants.
Director Douglas Wurth recently increased his personal stake in Bluejay Diagnostics, Inc. (NASDAQ:BJDX) through a direct purchase of common stock. This transaction occurred against the backdrop of broader company actions, including another private placement raise by board members, the exercise of prefunded warrants, and ongoing financial reporting.
The Chief Executive Officer of Bluejay Diagnostics, Inc., Indranil Dey, recently purchased a significant block of common stock directly from the company. This transaction occurs while the stock trades near its 52-week low, amidst several other reported financial adjustments, including private placements and warrant exercises by board members.
The Chief Accounting Officer of Equitable Holdings, Inc., William James Eckert IV, recently sold a notable quantity of company shares. This activity occurs against the backdrop of the firm reporting strong first-quarter earnings that surpassed market expectations, alongside revenue growth figures that suggest solid operational health for the compan…
Bluejay Diagnostics, Inc.'s director, Fred S Zeidman, recently purchased 12,500 shares of the company's common stock through a private placement. This transaction occurred while the stock traded near its recent 52-week low and is set against a backdrop of other corporate actions, including additional board member investments and warrant exercises.
Jeffrey J. Hurd, Chief Operating Officer of Equitable Holdings (EQH), sold a total value of approximately $609,418 worth of common stock on May 15, 2026. This activity occurred alongside the company's reporting of strong first-quarter financial results for 2026, including earnings and revenue surprises.
Bluejay Diagnostics, Inc. (NASDAQ:BJDX) director Svetlana Dey reported acquiring $25,000 worth of the company's common stock on March 14, 2026. This transaction occurred while the stock was trading near its 52-week low and amidst broader corporate activities including a recent private placement by board members and the full exercise of prefunded wa…
